Q4 & Year-End 2022

Results & 2023 Outlook

January 25, 2023

Executing our Strategy to Accelerate Growth

with Strong Commercial Capabilities

Consumer Inspired

Superior

Innovation

In-Market Execution

Iconic Digital-First

Revenue Growth

Brands

Management

OUR PURPOSE

Better Care for a Better world

Ac

hieve

d

B

a

l

a

n

ce

d

a

n

d

S

u

a

le

stain

b

s

le

Sa

2

2

0

2

in

h

t

w

ro

G

NET SALES

ORGANIC SALES GROWTH1

GROSS MARGIN2

ADJUSTED

OPERATING MARGIN3

2022

5B

5

+270

+200

Q4

$

%

Flat YoY

Excludes FX -500 bps

BPS YoY 32.8%

BPS YoY 14.3%

FY

$20B

7%

-80

-160

2022

+4% YoY

Excludes FX -400 bps

BPS YoY 30.8%

BPS YoY 13.0%

Healthy Organic Growth1 on 1-Year and 3-Year Average

2022

3 Year Average ['19-'22]

Total Company

Personal Care

+7%

+7%

+6%

+4%

2022 Overview

Grew portfolio of iconic brands

Grew or held market share in ~50% of markets

Innovation, advertising investments, commercial execution drove growth momentum

Price net of input cost and currencies impact turning positive in the second half of 2023

Consumer Tissue

KC-Professional

+7%

+9%

+3%

+1%

Sequentially improved gross and operating margins as pricing continued to build and input costs eased off peak levels in Q4

Revenue growth management actions strengthened QoQ

Continued margin recovery while investing

Delivered $1.7B in dividends and share repurchases

2023 Outlook4

Sustainable Growth and Margin Recovery

  • Maintain topline growth momentum with pipeline of innovation, commercial agility and disciplined investment
  • Gross margin improvement to fuel continued growth investments

2 - 4%

-200 bps

+MSD - HSD

Gross

+100 bps

2 - 6%

ORGANIC

SALES IMPACT

OPERATING

Margin

ADVERTISING

EPS GROWTH5

SALES GROWTH1

from FX

PROFIT GROWTH5

Recovery

investment to fuel

with higher

driven by strong

Operating margin

sales growth and

interest rates,

Revenue growth

pricing, market

up ~80 bps at the

scale innovation

effective tax rate

share gains and

midpoint

management,

expansion

cost discipline,

in growth markets

innovation offset

input/mfg cost

increases

Capital Allocation Aligned with Value Creation Priorities

Dividend Per Share

Invest in Our Business

(declared)

$4.64

Building Future Capabilities

+5%

$2.96

CAGR

Grow the Dividend

Share Repurchases

2012

2022

Value Creating M&A

  1. Organic net sales describes the impact of changes in volume, net selling prices and product mix on net sales. Changes in foreign currency exchange rates, acquisitions and exited businesses are excluded from organic growth.
  2. Compared to 2021 adjusted gross margin.
  3. Non-GAAPmeasure. Please see the company's Q4 2022 earnings press release for more information and a reconciliation to comparable measures under GAAP. The earnings release can be found on our website at www.kimberly-clark.comunder the Investors section, or via the following link: www.kimberly-clark.com/investors.
  4. Certain matters contained in this Infographic concerning the outlook, anticipated financial and operating results, growth initiatives and the anticipated cost savings from the company's FORCE program constitute forward-looking statements and are based upon management's expectations and beliefs concerning future events impacting the company. Many factors outside our control, including the war in Ukraine (including the related responses of consumers, customers and suppliers as well as sanctions issued by the U.S., the European Union, Russia or other countries), pandemics (including the ongoing COVID-19 outbreak and the related responses of governments, consumers, customers, suppliers and employees), epidemics, the prices and availability of our raw materials, supply chain disruptions, failure to realize the expected benefits or synergies from our acquisition and disposition activity (including our pending agreement to sell our Neve tissue brand and associated assets in Brazil), changes in customer preferences, severe weather conditions, government trade or similar regulatory actions, potential competitive pressures on selling prices for our products, energy costs, fluctuations in foreign currency exchange rates, our ability to maintain key customer relationships, as well as general economic and political conditions globally and in the markets in which we do business, could affect the realization of these estimates. There can be no assurance that these future events will occur as anticipated or that the company's results will be as estimated. Forward-looking statements speak only as of the date they were made, and we undertake no obligation to publicly update them. For a description of certain factors that could cause the company's future results to differ from those expressed in any such forward-looking statements, see Item 1A entitled "Risk Factors" in the company's Annual Report on Form 10-K for the year ended December 31, 2021.
  5. Compared to 2022 adjusted results.

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Kimberly-Clark Corporation published this content on 25 January 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 25 January 2023 13:07:04 UTC.